Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFSI
2976
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $622K | ﹤0.01% |
61,796
| – | – |
|
|
GNCMA
2977
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $622K | ﹤0.01% |
15,932
-4,459
| -22% | -$182K |
|
2978
Nomura Holdings
NMR
$29B
| $621K | ﹤0.01% |
106,673
+58,473
| +121% | +$339K |
|
|
INFN
2979
DELISTED
Infinera Corporation Common Stock
INFN
| $621K | ﹤0.01% |
+98,077
| New | +$747K |
|
|
LRFC
2980
DELISTED
Logan Ridge Finance Corp
LRFC
| $620K | ﹤0.01% |
14,191
-2,652
| -16% | -$129K |
|
2981
Winmark
WINA
$1.25B
| $620K | ﹤0.01% |
+4,795
| New | +$634K |
|
2982
CVB Financial
CVBF
$3.94B
| $618K | ﹤0.01% |
26,222
+3,852
| +17% | +$91.5K |
|
|
UBA
2983
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $618K | ﹤0.01% |
28,405
-86,255
| -75% | -$1.93M |
|
2984
Malibu Boats
MBUU
$559M
| $617K | ﹤0.01% |
20,743
-154,003
| -88% | -$4.7M |
|
|
BETR
2985
DELISTED
Amplify Snack Brands, Inc.
BETR
| $617K | ﹤0.01% |
+51,408
| New | +$370K |
|
2986
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$276M
| $616K | ﹤0.01% |
+25,632
| New | +$590K |
|
2987
Savara
SVRA
$1.15B
| $615K | ﹤0.01% |
41,441
-259,215
| -86% | -$2.97M |
|
2988
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.64B
| $614K | ﹤0.01% |
10,112
+6,472
| +178% | +$385K |
|
2989
Corvus Pharmaceuticals
CRVS
$1.22B
| $611K | ﹤0.01% |
59,017
+37,998
| +181% | +$487K |
|
2990
NN Inc
NNBR
$292M
| $610K | ﹤0.01% |
+22,086
| New | +$627K |
|
2991
PUT
Exelixis
EXEL
$14.1B
| $608K | ﹤0.01% |
20,000
-4,300
| -18% | -$114K |
|
|
DO
2992
DELISTED
Diamond Offshore Drilling
DO
| $607K | ﹤0.01% |
32,672
-655,039
| -95% | -$10.7M |
|
2993
PhenixFIN
PFX
$102M
| $606K | ﹤0.01% |
5,805
-360
| -6% | -$41.1K |
|
|
CBAY
2994
DELISTED
Cymabay Therapeutics
CBAY
| $604K | ﹤0.01% |
65,681
-1,637,443
| -96% | -$14M |
|
|
DRNA
2995
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $604K | ﹤0.01% |
66,907
+39,348
| +143% | +$289K |
|
2996
Sinclair Inc
SBGI
$1.06B
| $600K | ﹤0.01% |
+15,852
| New | +$525K |
|
|
DOC
2997
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $600K | ﹤0.01% |
33,360
-426,755
| -93% | -$7.65M |
|
|
CATC
2998
DELISTED
CAMBRIDGE BANCORP
CATC
| $598K | ﹤0.01% |
+7,499
| New | +$566K |
|
2999
Sabesp
SBS
$16.9B
| $597K | ﹤0.01% |
294,520
-2,192,821
| -88% | -$4.21M |
|
3000
Charles River Laboratories
CRL
$14.2B
| $595K | ﹤0.01% |
5,433
-216,504
| -98% | -$23.6M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.